Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 256,739 | 310,619 | 283,153 | 455,814 | 347,121 |
| Receivables | 663,762 | 629,261 | 653,139 | 531,702 | 640,302 |
| Inventories | 489,389 | 520,245 | 523,385 | 497,008 | 490,649 |
| TOTAL | $1,520,108 | $1,570,337 | $1,563,475 | $1,559,661 | $1,551,539 |
| Non-Current Assets | |||||
| PPE Net | 514,158 | 459,651 | 468,415 | 471,165 | 477,754 |
| Intangibles | 1,759,939 | 1,799,133 | 1,842,416 | 1,785,712 | 1,827,440 |
| Other Non-Current Assets | 145,459 | 145,288 | 148,747 | 143,532 | 149,300 |
| TOTAL | $2,419,556 | $2,404,072 | $2,459,578 | $2,400,409 | $2,454,494 |
| Total Assets | $3,939,664 | $3,974,409 | $4,023,053 | $3,960,070 | $4,006,033 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 30,614 | 30,471 | 30,461 | 29,817 | 44,228 |
| Accounts payable and accrued liabilities | 573,206 | 621,886 | 629,157 | 594,422 | 619,428 |
| Other current liabilities | 58,000 | N/A | N/A | N/A | N/A |
| TOTAL | $677,243 | $667,335 | $672,862 | $636,779 | $676,902 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,718,091 | 2,725,297 | 2,757,341 | 2,765,040 | 2,771,704 |
| Other Non-Current Liabilities | 193,294 | 198,611 | 184,934 | 183,704 | 169,285 |
| TOTAL | $2,895,448 | $2,923,908 | $2,959,919 | $2,956,583 | $2,984,199 |
| Total Liabilities | $3,572,691 | $3,591,243 | $3,632,781 | $3,593,362 | $3,661,101 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 301,541 | 301,488 | 301,395 | 300,837 | 299,821 |
| Common Shares | 3,014 | 3,014 | 3,012 | 3,007 | 2,997 |
| Retained earnings | -276,197 | -269,820 | -265,583 | -280,115 | -286,821 |
| Other shareholders' equity | -18,194 | -567 | 10,186 | 9,332 | 343 |
| TOTAL | $366,973 | $383,166 | $390,272 | $366,708 | $344,932 |
| Total Liabilities And Equity | $3,939,664 | $3,974,409 | $4,023,053 | $3,960,070 | $4,006,033 |